Ipilimumab versus placebo after complete resection of stage III melanoma: Long-term follow-up results the EORTC 18071 double-blind phase 3 randomized trial Meeting Abstract
| Authors: | Eggermont, A. M. M.; Chiarion-Sileni, V.; Grob, J. J.; Dummer, R.; Wolchok, J. D.; Schmidt, H.; Hamid, O.; Robert, C.; Ascierto, P. A.; Richards, J. M.; Lebbe, C.; Ferraresi, V.; Smylie, M.; Weber, J. S.; Maio, M.; Hosein, F.; de Pril, V.; Kicinski, M.; Suciu, S.; Testori, A. |
| Abstract Title: | Ipilimumab versus placebo after complete resection of stage III melanoma: Long-term follow-up results the EORTC 18071 double-blind phase 3 randomized trial |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 109s |
| Language: | English |
| ACCESSION: | WOS:000487345804464 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.2512 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2512 -- Source: Wos |
